CapsoCam SV-1 Versus PillCam SB 3 in the Detection of Obscure Gastrointestinal Bleeding

Zwinger, Lilli L; Siegmund, Britta; Stroux, Andrea; Adler, Andreas; Veltzke‐Schlieker, Wilfried; Wentrup, Robert; Jürgensen, Christian; Wiedenmann, Bertram; Wiedbrauck, Felix; Hollerbach, Stephan; Liceni, Thomas; Bojarski, Christian

doi:10.1097/mcg.0000000000000994

Cited by 32 publications

(26 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…They showed that the performance of CapsoCam SV‐1 was similar to that of a forward‐view SBCE system. Zwinger et al . conducted a head‐to‐head comparison between CapsoCam SV‐1 and PillCam SB3 in a randomized prospective study enrolling patients with obscure gastrointestinal bleeding (OGIB).…”

Section: Current Status Of Sbce Devicesmentioning

confidence: 99%

“…They showed that the performance of CapsoCam SV-1 was similar to that of a forwardview SBCE system. Zwinger et al 18 conducted a head-to-head comparison between CapsoCam SV-1 and PillCam SB3 in a randomized prospective study enrolling patients with obscure gastrointestinal bleeding (OGIB). They reported that CapsoCam SV-1 detected more bleeding lesions (31/79) and had a higher diagnostic yield (39.7%) as compared with PillCam SB3 (26/75 and 34.6%, respectively).…”

Section: Current Status Of Sbce Devicesmentioning

confidence: 99%

See 1 more Smart Citation

Capsule endoscopy for small‐intestinal disorders: Current status

Hosoe

Takabayashi

Ogata

et al. 2019

Digestive Endoscopy

View full text Add to dashboard Cite

Small‐bowel capsule endoscopy (SBCE) is used widely because of its non‐invasive and patient‐friendly nature. SBCE can visualize entire small‐intestinal mucosa and facilitate detection of small‐intestinal abnormalities. In this review article, we focus on the current status of SBCE. Several platforms for SBCE are available worldwide. Third‐generation SBCE (PillCam® SB3) has a high‐resolution camera equipped with an adaptive frame rate system. Several software modes have been developed to reduce the reading time for capsule endoscopy and to minimize the possibility of missing lesions. The main complication of SBCE is capsule retention. Thus, the main contraindication for SBCE is known or suspected gastrointestinal obstruction unless intestinal patency is proven. Possible indications for SBCE are obscure gastrointestinal bleeding, Crohn's disease, small‐intestinal polyps and tumors, and celiac disease. Colon capsule endoscopy (CCE) can observe inflamed colonic mucosa non‐invasively, and allows for the continuous and non‐invasive observation of the entire intestinal tract (pan‐endoscopy). Recently, application of CCE as pan‐enteric endoscopy for inflammatory bowel diseases (including Crohn's disease) has been reported. In the near future, reading for CE will be assisted by artificial intelligence, and reading CE videos for long periods will not be required.

show abstract

Section: Current Status Of Sbce Devicesmentioning

confidence: 99%

Section: Current Status Of Sbce Devicesmentioning

confidence: 99%

Capsule endoscopy for small‐intestinal disorders: Current status

Hosoe

Takabayashi

Ogata

et al. 2019

Digestive Endoscopy

View full text Add to dashboard Cite

show abstract

“…Serious adverse events were 0% with PillCam SB3 and 1.3% with CapsoCam SV-1. 15 CE is superior to other techniques in diagnosing the source of bleeding. A pooled analysis of 14 studies including 396 patients showed a diagnostic yield of 56% for CE versus 26% (p = 0.00001) for push enteroscopy.…”

Section: Clinical Evidence For Use Obscure Gastrointestinal Bleedingmentioning

confidence: 97%

Capsule Endoscopy: What We Know and What Is New in the Horizon

Chauhan

Tanwar

Nijhawan

2019

Journal of Digestive Endoscopy

View full text Add to dashboard Cite

Capsule endoscopy (CE) is an advancing noninvasive technology primarily meant for small-bowel visualization, which has expanded its scope and has become a game changer in evaluation and management of various gastrointestinal (GI) diseases with special emphasis on obscure GI bleeding. The aim of this review is to know the basic aspects of CE and recent advances with clinical evidence. AbstractKeywords ► capsule endoscopy ► celiac disease ► Crohn's disease ► obscure gastrointestinal bleed ► small bowel

show abstract

“…Literature on axial and panoramic SBCE in obscure gastrointestinal bleeding (OGIB) is limited . We carried out a retrospective study on 94 patients with overt OGIB where findings on gastroduodenoscopy were inadequate to explain presentation (SBCE after a median 28 days).…”

Section: Diagnostic Yield (Dy) Of Panoramic and Axial Small Bowel Capmentioning

confidence: 99%